Covidien (FRA:6COP) 5-Year Yield-on-Cost % : 3.30 (As of May. 07, 2024)

View and export this data going back to . Start your Free Trial

What is Covidien 5-Year Yield-on-Cost %?

Covidien's yield on cost for the quarter that ended in Dec. 2014 was 3.30.

The historical rank and industry rank for Covidien's 5-Year Yield-on-Cost % or its related term are showing as below:

FRA:6COP' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.14 Med: 4.93 Max: 7.33
Current: 3.3

During the past 13 years, Covidien's highest Yield on Cost was 7.33. The lowest was 1.14. And the median was 4.93.

FRA:6COP's 5-Year Yield-on-Cost % is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 2.21 vs FRA:6COP: 3.30

Competitive Comparison of Covidien's 5-Year Yield-on-Cost %

For the Medical Instruments & Supplies subindustry, Covidien's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Covidien's 5-Year Yield-on-Cost % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Covidien's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Covidien's 5-Year Yield-on-Cost % falls into.

Covidien 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Covidien is calculated as

Yield-on-Cost

Dividend Yield %

Dividend Growth Rate)^5

Covidien (FRA:6COP) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.

Covidien 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Covidien's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.

Covidien (FRA:6COP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Covidien PLC (FRA:6COP) » Definitions » 5-Year Yield-on-Cost %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.covidien.com

Covidien PLC formerly known as Covidien Ltd. was incorporated in Bermuda in 2000 as a wholly-owned subsidiary of Tyco International Ltd. In June 2009, Covidien plc announced that one of its subsidiaries has completed the acquisition of VNUS Medical Technologies, Inc. In September 2009, the Company completed the acquisition of Power Medical Interventions Inc. In November 2009, the Company completed the acquisition of Aspect Medical Systems Inc. The Company is engaged in the development, manufacture and sale of healthcare products for use in clinical and home settings. Its products are found in almost every hospital in the United States. Its mission is to create and deliver innovative healthcare solutions, developed in ethical collaboration with medical professionals. It operates through two segments: Medical Devices and Medical Supplies. The Medical Devices segment includes the development, manufacture and sale of endomechanical instruments, energy devices, soft tissue repair products, vascular products, oximetry and monitoring products, airway and ventilation products, and other medical products. The Medical Supplies segment includes the development, manufacture and sale of nursing care products, medical surgical products, SharpSafety products and original equipment manufacturer products. Competitors of Medical Devices segment include diversified healthcare companies, such as Johnson & Johnson, Boston Scientific, Baxter and C.R. Bard. Its Nursing Care products include: Curity and Kerlix and Medical Surgical products include: Medi-Trace. The Company holds more than 13,000 patents and have over 10,500 patent applications pending in the United States and in certain other countries that relate to aspects of the technology used in many of its products. The Company is subject to numerous federal, state and local environmental protection and health and safety laws and regulations both within and outside the United States.

Covidien (FRA:6COP) Headlines

No Headlines